WASHINGTON DC (July 10, 2020) — The US Food and Drug Administration has been thoughtfully and deliberately determining the safest and most appropriate time to resume prioritized domestic-inspections of FDA-regulated facilities and other associated activities since we first announced postponement in March. The White House Guidelines for Opening Up America Again ar